Tim Luetkens

2.3k citations
69 papers · 1.9k · h-index 27

Impact in

  • Hematology top 2%
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Multiple Myeloma Research and Treatments 27
    • CAR-T cell therapy research 17
    • Cancer Immunotherapy and Biomarkers 7

Tim Luetkens

67 papers receiving 1.9k citations

Peers

Tim Luetkens
Comparison fields: 5 of 73
  • Hematology 577
  • Oncology 662
  • Immunology 350
  • Biological Psychiatry 10
  • Behavioral Neuroscience 20
Replace Ling Hui Xu with:
Ling Hui Xu China
Helios R. Recalde Italy
Yasunori Ota Japan
Anushruti Sarvaria United States
Christine M. Canning United States
Francesca Moretta Italy
Barbara Oliviero Italy
Willemijn A. Hobo Netherlands
Steven K. Grossenbacher United States
Anne Maria Tierens Norway
Tim Luetkens relative to Ling Hui Xu China Ling Hui Xu's profile →
Citations per field
00.5×2×4×6×8×10×
Ling Hui Xu · 1×
Citations per year

Countries citing papers authored by Tim Luetkens

Since Specialization
Citations

This map shows the geographic impact of Tim Luetkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Luetkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Luetkens more than expected).

Fields of papers citing papers by Tim Luetkens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Luetkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Luetkens. The network helps show where Tim Luetkens may publish in the future.

Co-authors

The 25 scholars most cited alongside Tim Luetkens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Luetkens Line = papers co-authored together Tim Luetkens links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008110
2 201198
3 201394
4 200988
5 202288
6 201585
7 201078
8 200970
9 200966
10 202066
11 202066
12 200858
13 200956
14 201655
15 201451
16 201048
17 201041
18 201439
19 201638
20 201032

About Tim Luetkens

Tim Luetkens is a scholar working on Hematology, Oncology, Immunology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 69 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (27 papers), CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (577 citations), Oncology (662 citations), Immunology (350 citations), Biological Psychiatry (10 citations) and Behavioral Neuroscience (20 citations). Tim Luetkens has collaborated with scholars based in United States, Germany and Nigeria. Frequent co-authors include Djordje Atanackovic, Nicolaus Martin Kröger, Carsten Bokemeyer, Sabarinath Venniyil Radhakrishnan, Katrin Bartels, York Hildebrandt, Yanran Cao, Sebastian Kobold, Michael Olson and Mary Nicole Steinbach. Their work appears in journals such as Blood, Haematologica, Human Vaccines & Immunotherapeutics, Leukemia and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact